Chamber releases new plan for reopening, recovery
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Opinion: A guide to state programs to stop the spread of COVID in the workplace
By Kim L. Hunter It’s difficult to try to understand how much the world has changed in just one short year. What started off as sheltering in place, attempting to master the art of baking sourdough bread from scratch, soon turned into unprecedented loss in every sense of the word. From loss of life to Read More →
UCLA opens cancer clinic in Santa Barbara
UCLA Health has opened a new cancer care clinic near Cottage Hospital in Santa Barbara. The new clinic, at 309 W. Quinto St., will expand treatment options for residents of Santa Barbara and the surrounding areas, as they will be able to get regular treatment and participate in more than 600 UCLA cancer clinical trials Read More →
Amgen to lay off hundreds, including in Thousand Oaks
Biotech giant Amgen is in the process of laying off hundreds of workers, including as many as 100 at its Thousand Oaks headquarters. According to a spokesperson for the company, approximately 500 workers will be let go beginning April 2. Less than 20% of those workers are located in Thousand Oaks. Amgen employs around 22,000 Read More →
Amgen shares slip after projections of flat 2021 sales
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Amgen reports rising revenue, warns of flat 2021
Amgen, one of the world’s largest biotech companies, saw rising revenue in the fourth quarter of 2020, but the COVID-19 pandemic could dampen the outlook for the company and its investors in 2021, according to earnings released Feb. 2. The Thousand Oaks-based biotech firm had $6.6 billion in revenue in the fourth quarter, a 7% Read More →
Arcutis stock soars on drug trial news; company announces $150M capital raise
Stock of Arcutis Biotherapeutics, a Westlake Village-based company developing dermatological treatments, shot up more than 30% on Feb. 1 after the company released positive results from a recent clinical trial. Later in the day, Arcutis said it plans to sell $150 million worth of its common stock. Before stock trading opened, the company announced positive Read More →
